Stock listing

Frankfurt:2OK SpectraCure AB Aktie

German listing (Frankfurt) of SpectraCure AB · home listing Stockholm:SPEC

Follow SpectraCure AB into a list and get an email when it puts out news.

Share price · FWB:2OK

€0.0010 EUR

Close on Nov 20, 2026

Past year -80.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€0.0010 – €0.0010 EURNov 20, 2026
Market cap
€735,490 EURAt the close on Nov 20, 2026 · price × 735.5M shares outstanding
52-week range
€0.0010 – €0.0060 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
SpectraCure AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:SPEC · Home0.014 SEK+0.001 (+7.9%)5,100,0360.0120.0140.0120.013Close on Nov 20, 2026
Frankfurt:2OK€0.0010 EUR——€0.0010€0.0010€0.0010—Close on Nov 20, 2026
Ticker
Frankfurt:2OK
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All SpectraCure AB news

SpectraCure AB on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
5 in the last 12 months · 24 in all · newest Jun 1, 2026 · oldest 2020
Decks
3 decks · latest December 2024

Where SpectraCure AB is listed

ListingExchangeCountryCurrency
Stockholm:SPEC · Home listingStockholmSwedenSEK
Frankfurt:2OK · This pageFrankfurtGermanyEUR

Valuation

EV/sales 32.1× against a median of 0.2×: the highest of 7 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
11.28M SEK
P/E
Loss
EV/sales
32.1×
EV/EBITDA
Negative EBITDA
Price/book
0.1×
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.1×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
SpectraCure AB · OMXSTO:SPECUS$981,033US$1.11Mn/a32.1×n/a0.1×n/a0.1×n/a
Nuwellis, Inc. · NASDAQ:NUWEUS$1.84M−US$6.31Mn/a−0.7×n/a0.2×−152.8%0.0×2.26
Vivos Therapeutics, Inc. · NASDAQ:VVOSUS$1.83MUS$2.11Mn/a0.1×n/a0.8×−107.1%0.2×1.41
Autonomix Medical, Inc. · NASDAQ:AMIXUS$1.82M−US$5.87Mn/an/an/a0.3×n/a0.0×1.79
Adagio Medical Holdings, Inc · NASDAQ:ADGMUS$1.72MUS$636,0102.1×n/an/a0.1×n/a0.1×0.69
Escalon Medical Corp. · OTC:ESMCUS$1.71M−US$1.96M0.4×−0.1×n/a0.3×32.8%0.0×-0.06
Therma Bright Inc. · TSXV:THRMUS$1.66MUS$1.64Mn/a17.3×n/an/an/an/a-0.15
Nexalin Technology, Inc. · NASDAQ:NXLUS$1.45MUS$1.88Mn/a6.8×n/a5.5×n/a4.7×0.52
Zero Candida Technologies Inc. · TSXV:ZCTUS$1.43M−US$59,297n/an/an/a2.2×n/a0.0×-0.17
Osteopore Ltd. · ASX:OSXUS$1.38MUS$596,514n/a0.3×n/an/a−121.8%n/an/a
Odyssey Health Inc. · OTC:ODYYUS$716,421US$594,060n/an/an/an/an/an/a0.58
Median of the othersUS$1.68MUS$595,2871.2×0.2×0.3×−114.5%0.0×0.58

Team and board

DirectorRole
Jörgen WennbergChairman of the Board
Jesper FreijBoard member
Masoud KhayyamiBoard member
Patrik RingblomBoard member
Stefan Andersson-EngelsBoard member
Tomas KramarBoard member

Events

QuarterResultsShare move
Q1 2024May 15, 2024 · Before open−3.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (December 2024)Investor deck23 slidesDecember 2024
Shareholder Meeting (May 2022)Shareholder meeting12 slidesMay 12, 2022
Shareholder Meeting (May 2022)Shareholder meeting11 slidesMay 12, 2022

Open Decks

Financings

RaiseDateIn US dollars
Rights offering of rights issue
Closed: SEK 54.8M raised
Use of proceeds: To support ongoing clinical trials
Aug 15, 2025US$5.74M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue868.0K19.5M318.0K539.0K5.75M1.21K763596.0K259.0K172.9K
Cost of revenue30.1M9.77M9.54M-3.05M-1.39M-2.35M-2.62M-2.13M-1.55M-1.14M
Gross profit-30.1M9.77M-9.22M3.58M1.39M2.35M2.62M2.72M1.81M1.31M
Selling, general and administrative13.4M12.3M12.7M11.6M10.7M8.32M7.82M6.55M5.93M5.21M
Operating income-54.4M-24.5M-21.4M-27.0M-24.4M-16.5M-14.3M-9.62M-8.70M-6.82M
Depreciation and amortization2.55M2.63M2.66M2.93M2.67M2.28M2.12M150.0K1.17M136.8K
EBITDA-51.8M-21.9M-18.7M-24.0M-21.8M-14.2M-12.2M-9.47M-7.53M-6.68M
Interest expense1.25M468.0K522.0K182.0K245.0K276.0K224.0K06443.5K
Income before tax-56.1M-23.0M-20.5M-25.4M-23.3M-15.4M-13.7M-9.61M-8.70M-6.37M
Income tax27.0K-7.00K-21.0K-53.0K-5.00K-30.0K-7.00K167.0K51550
Net income-56.1M-23.0M-20.4M-25.3M-23.3M-15.4M-13.7M-9.61M-8.70M-6.37M
Earnings per share, basic-0.14-0.24-0.21-0.26-0.24-0.17-0.16-0.12-0.15-0.21

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents13.5M18.3M57.0M93.2M129.7M157.2M54.2M45.1M2.44M381.7K
Receivables2.21M3.62M183.0K1.10M1.08M872.0K842.0K1.80M249.5K19.6M
Inventory10-100-13.0K-4.40K-19.2M
Current assets16.2M22.2M58.7M94.3M130.8M158.4M56.8M47.5M2.91M20.0M
Property, plant and equipment3.05M5.40M6.95M3.96M6.18M6.71M7.99M132.0K193.7K121.1K
Total assets104.5M121.0M144.8M162.4M190.5M210.5M100.2M68.9M14.7M28.8M
Accounts payable1.71M3.32M1.04M1.61M1.83M59.0K1.75M1.56M391.7K3.04M
Current liabilities10.7M11.5M10.6M11.8M12.4M9.86M7.55M4.03M1.30M6.66M
Total debt3.01M5.14M6.72M2.70M4.90M5.36M6.71M
Total liabilities10.9M14.1M15.0M12.1M14.8M13.3M12.4M4.03M1.30M6.66M
Shareholders' equity93.5M106.9M129.9M150.3M175.7M197.2M87.8M64.9M13.4M22.1M
Shares outstanding409.7M97.1M97.1M97.1M97.1M92.4M83.1M78.4M57.1M30.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-24.0M-21.8M-18.7M-23.0M-18.6M-9.40M-10.1M-8.97M6.33M-19.6M
Capital spending-19.6M-15.3M-15.8M-10.1M-8.49M-10.6M-15.1M-9.39M-4.27M-3.80M
Free cash flow-43.7M-37.1M-34.4M-33.1M-27.1M-20.0M-25.2M-18.4M2.06M-23.4M
Cash from investing-19.6M-15.3M-15.6M-11.3M-8.49M-10.6M-15.1M-9.39M-4.27M-3.62M
Cash from financing38.9M-1.57M-1.99M-2.20M-453.0K123.0M34.3M50.6M67.5M15.4M
Share buybacks54.8M0139.9M37.9M57.6M015.4M
Change in cash-4.75M-38.7M-36.2M-36.5M-27.5M103.0M9.13M32.2M2.06M-7.79M

Open Financials

Cap table

Built by 6ix from SpectraCure AB’s releases · as of Aug 15, 2025

Common shares
735,491,879
Fully diluted
735,491,879

Fully diluted

LineShares
Common shares735,491,879

Share count over time

CountShares
Nov 22, 2026735,491,879

Open Cap table

Shareholders

InsiderTradeSharesPriceValueDate
Masoud Khayyami
Member of the Board of Directors
Buy3,000,000SEK 0.02SEK 62,700Sep 18, 2026
Jörgen Wennberg
Chairman of the Board of Directors
Buy2,000,000SEK 0.02SEK 48,800Sep 1, 2026
Masoud Khayyami
Member of the Board of Directors
Buy571,705SEK 0.03SEK 17,151Aug 28, 2026
MK Capital Invest AB
Member of the Board of Directors
Buy38,334,782SEK 0.03SEK 1.15MAug 4, 2026
Masoud Khayyami
Member of the Board of Directors
Buy950,000SEK 0.10SEK 95,000Jan 28, 2026
Masoud Khayyami
Member of the Board of Directors
Sale916,870SEK 0.10SEK 87,103Jan 28, 2026
Jörgen Wennberg
Chairman of the Board of Directors
Buy700,000SEK 0.12SEK 84,000Jan 12, 2026
Masoud Khayyami
Member of the Board of Directors
Buy393,061SEK 0.13SEK 49,133Jan 12, 2026
Masoud Khayyami
Member of the Board of Directors
Buy529,876SEK 0.12SEK 64,115Jan 9, 2026
Masoud Khayyami
Member of the Board of Directors
Buy662,685SEK 0.13SEK 88,800Jan 8, 2026
All 20 trades
InsiderTradeSharesPriceValueDate
Masoud Khayyami
Member of the Board of Directors
Buy67,294SEK 0.15SEK 9,960Jan 7, 2026
Masoud Khayyami
Member of the Board of Directors
Buy31,088SEK 0.15SEK 4,663Jan 5, 2026
Cardeon AB (publ)
Chief Executive Officer (CEO)/Managing Directory
Sale300,000SEK 0.15SEK 44,700Dec 30, 2025
MK Capital Invest AB
Member of the Board of Directors
Sale216,719SEK 0.16SEK 34,242Dec 30, 2025
MK Capital Invest AB
Member of the Board of Directors
Sale531,058SEK 0.16SEK 82,845Dec 29, 2025
MK Capital Invest AB
Member of the Board of Directors
Sale428,441SEK 0.16SEK 70,264Dec 22, 2025
Masoud Khayyami
Chief Executive Officer (CEO)/Managing Directory
Buy81,777SEK 0.17SEK 13,575Dec 15, 2025
Jörgen Wennberg
Chairman of the Board of Directors
Buy300,000SEK 0.17SEK 50,700Dec 15, 2025
Masoud Khayyami
Member of the Board of Directors
Buy175,120SEK 0.17SEK 28,895Dec 9, 2025
Masoud Khayyami
Member of the Board of Directors
Buy592,260SEK 0.17SEK 98,671Dec 8, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jesper FreijBoard member · Since at least Nov 5, 2026
Jörgen WennbergChairman of the Board · Since at least Nov 5, 2026
Masoud KhayyamiBoard member · Since at least Oct 1, 2025
Patrik RingblomBoard member · Since at least Nov 5, 2026
Stefan Andersson-EngelsBoard member · Since at least Nov 5, 2026
Tomas KramarBoard member · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about SpectraCure AB.